Evidence map›Paper›PMID 33511031›Full record

ArticleMetabolic engineering communications2021

Fabian Brandenburg, Eleni Theodosiou, Carolin Bertelmann, Marcel Grund, Stephan Klähn, Andreas Schmid, Jens O Krömer

Open access · goldAbstract read
In one paragraph

Article in Metabolic engineering communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Co-expression of auxiliary genes enhances the activity of a heterologous OBiotechnology for biofuels and bioproducts · 2025
    Article
  5. Review
  6. Article
  7. DegS regulates the aerobic metabolism ofFrontiers in cellular and infection microbiology · 2024
    Article
  8. Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM) · 2023
    Review
  9. Article
  10. The Molecular Toolset and Techniques Required to Build Cyanobacterial Cell Factories.Advances in biochemical engineering/biotechnology · 2023
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fabian BrandenburgDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Eleni TheodosiouDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Carolin BertelmannDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Marcel GrundDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Stephan KlähnDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Andreas SchmidDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Jens O KrömerDepartment of Solar Materials, Helmholtz-Centre for Environmental Research - UFZ, Leipzig, Germany.
Helmholtz Centre for Environmental Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyanobacteria play an important role in photobiotechnology. Yet, one of their key central metabolic pathways, the tricarboxylic acid (TCA) cycle, has a unique architecture compared to most heterotrophs and still remains largely unexploited. The conversion of 2-oxoglutarate to succinate via succinyl-CoA is absent but is by-passed by several other reactions. Overall, fluxes under photoautotrophic growth conditions through the TCA cycle are low, which has implications for the production of chemicals. In this study, we investigate the capacity of the TCA cycle of

Indexed as

CyanobacteriaLand usepHProline-4-hydroxylaseTCA cycletrans-4-Hydroxy-L-proline

Identifiers

PMID33511031
PMCPMC7815826
OpenAlexW3116180889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.